Dow Jones Top Company Headlines at 7 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
The results from a Merck-Moderna partnership validate years of research into a new approach to cancer treatment.
----
OpenAI's Latest Bid to Fight Anthropic: A Promise Not to Keep Customer Data
The ChatGPT maker hopes to win business customers who are upset that Anthropic is keeping their data.
----
Why a Payments Giant Is Paying $7 Billion for the 'Stripe of AI'
The Stripe deal for OpenRouter, founded by an NFT entrepreneur, is a bet on a future where users turn to a mix of AI models.
----
Target Raises Fiscal-Year Forecast Again as Turnaround Gains Traction
On the heels of a positive quarter, the retailer now expects sales growth of about 5% this fiscal year.
----
Strategy, Coinbase Stocks Rose After Trump Met Crypto Execs
Shares of Strategy were the best performer in the Nasdaq 100.
----
Women at L3Harris Shared Concerns About CEO's Behavior Years Before Ouster
Chris Kubasik was ousted after an investigation into conduct with a subordinate. Years earlier, another employee had made a harassment complaint.
----
T.J. Maxx Parent TJX Says Self-Inflicted Issues Hurt Sales
The company's U.S. apparel business fell short of quarterly expectations, signaling a pullback among shoppers even as the discount retailer raised its full-year earnings.
----
Lowe's Lowers Full-Year Targets as Homeowners Scale Back DIY Projects
Lowe's trimmed its full-year sales and profit targets, signaling that price-conscious homeowners are delaying major renovations and compounding back-half headwinds.
----
Carlyle Joins $1 Billion Investment Round in Missile Startup Castelion
The funding round, which also includes JPMorgan Chase and Andreessen Horowitz, values the hypersonic munitions maker at $13 billion.
----
Coty Looks to Finish Strategic Review, Guides for First-Quarter Sales Decline
The company guided for revenue to decline by a low- to mid-single-digit percentage as consumers become increasingly selective with their purchases, despite resilient demand for beauty overall.
----
Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills
The study will run into 2028, testing two low doses of Wegovy, and follows the company disclosing recently that uptake of the pill had been particularly strong for its lowest doses across self-paying patients.
----
Estee Lauder to Double Down on Turnaround Efforts as Sales Climb
The company narrowed its fiscal fourth-quarter loss as sales rose on broad-based strength across geographies and categories.
----
Amazon to Expand Drone Delivery Service to Nearly 500 Locales
The e-commerce giant to launch Prime Air in metro areas including Chicago, Atlanta, Cleveland, Syracuse, N.Y., and Boise, Idaho.
----
Analog Devices Profit, Revenue Up on Surging AI Data Center Demand
The semiconductor company reported higher profit and revenue in its third quarter driven by accelerating demand for data center hardware and industrial chips.
----
Chinese Humanoid Robot Leader Soars in Market Debut Despite U.S. Ban
Unitree Robotics is the first humanoid maker to list in mainland China.
(END) Dow Jones Newswires
August 19, 2026 19:15 ET (23:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
United States